Joshua Grass
Amministratore Delegato presso Meves Pharmaceuticals, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Marcus F. Boehm | M | 64 |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
| William Hodder | M | - |
NFlection Therapeutics, Inc.
 NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | 3 anni |
| Randy Meier | M | 65 | 18 anni | |
| Kathleen Glaub | F | 70 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 6 anni |
| George Davis | M | 53 | 20 anni | |
| Esther Martinborough | M | 58 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 6 anni |
| Philip Lo Scalzo | M | - | 17 anni | |
| Christian Weyer | M | 55 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 3 anni |
| Stuart Bunting | M | - | 16 anni | |
| Christopher Powala | M | 64 |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | - |
| Elaine Heron | M | 76 | 22 anni | |
| Brian Mueller | M | 50 | 22 anni | |
| Benjamin Auspitz | M | 51 |
Meves Pharmaceuticals, Inc.
 Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | - |
| Brad Glasscock | M | - | 12 anni | |
| Gregg Timony | M | - |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
| Henry Fuchs | M | 66 | 15 anni | |
| Peter Barber | M | - |
Meves Pharmaceuticals, Inc.
Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | - |
| Jeenjoo Kang | M | 40 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
| Amy Wireman | F | - | 11 anni | |
| Brinda Balakrishnan | M | 44 | 8 anni | |
| Corey Goodman | M | - |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | - |
| Katen Patel | M | - |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | - |
| Gerd Kochendoerfer | M | 56 |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | 3 anni |
| Jason Hafler | M | 42 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 4 anni |
| Eduardo Von Pervieux | M | - | 16 anni | |
| Rishi Gupta | M | 46 |
Meves Pharmaceuticals, Inc.
Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | - |
| K. Hirth | M | 72 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 5 anni |
| Raidy Kevin J. | M | 55 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | 4 anni |
| Kenneth Tsai | M | - |
NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | 6 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jean-Jacques Bienaimé | M | 70 | 19 anni | |
| Pierre LaPalme | M | 83 | 12 anni | |
| Jeff Ajer | M | 61 | 19 anni | |
| Alain D. Baron | M | 70 |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | - |
| V. Lawlis | M | 72 | 17 anni | |
| Alan J. Lewis | M | 78 | 15 anni | |
| Fredric D. Price | M | 78 | 4 anni | |
| Michael Grey | M | 71 | 16 anni | |
| Mark Wood | M | 57 | 9 anni | |
| Raymond Anderson | M | 82 | 4 anni | |
| Dennis Joseph Slamon | M | 75 | 10 anni | |
| Christopher Starr | M | 71 | 9 anni | |
| Sandra Shpilberg | F | 48 | 9 anni | |
| Dan Spiegelman | M | 65 | 8 anni | |
| William Young | M | 79 | 5 anni | |
| Kim Tsuchimoto | F | 61 | 8 anni | |
| Louis C. Drapeau | M | 79 | 3 anni | |
| Ken Bate | M | 73 | 7 anni | |
| Alejandro Dorenbaum | M | 64 | 7 anni | |
| Wolfgang Dummer | M | 58 | 4 anni | |
| Vassiliki Economides | F | 44 | 1 anni | |
| Vimal Srivastava | M | 58 | 2 anni | |
| John Urquhart | M | - | - | |
| Dan Oppenheimer | M | - | 14 anni | |
| Erin Jones | M | 52 | 2 anni | |
| Suyash Prasad | M | 54 | 4 anni | |
| Jackie Walling | M | - | 3 anni | |
| Christopher Schelling | M | 48 | 6 anni | |
| Edward Conner | M | 51 | 1 anni | |
| Camilla Simpson | F | 52 | 5 anni | |
| R. Ramelmeier | M | 62 | 8 anni | |
| Adam Shaywitz | M | - | 5 anni | |
| Min MIn Qin | M | 66 | 7 anni | |
| Elizabeth Ng | F | 67 | 7 anni | |
| Jonathan Heller | M | 49 | 2 anni | |
| Sarah Noonberg | M | 56 | 2 anni | |
| Robert A. Heft | M | 69 | 3 anni | |
| John Ditton | M | 60 | 2 anni | |
| Stephen Aselage | M | 73 | 7 anni | |
| Jeffrey Cooper | M | 68 | 9 anni | |
| Todd C. Zankel | M | 60 | 8 anni | |
| David Scott Geyer | M | 65 | 1 anni | |
| Joseph Klein | M | 62 | 5 anni | |
| Barrie J. Carter | M | 79 | 5 anni | |
| Richard Ranieri | M | 71 | 6 anni | |
| Emil Kakkis | M | 63 | 11 anni | |
| Erich Sager | M | 66 | 9 anni | |
| Vijay Samant | M | 77 | 2 anni | |
| Giles Campion | M | 69 | 1 anni | |
| Leonard Post | M | 72 | 6 anni | |
| Franz L. Cristiani | M | 83 | - | |
| Matt Patterson | M | 52 | 6 anni | |
| S. Michael Imperiale | M | - | - | |
| Gordon Vehar | M | - | - | |
| Bill Aliski | M | 75 | 3 anni | |
| Lewis Chapman | M | - | - | |
| David J. Ellam | M | - | 6 anni | |
| Scott Bizily | M | 52 | 9 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 87 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Joshua Grass
- Contatti personali
